While the reduction in price target could suggest a slightly less optimistic outlook on the stock's value, the maintenance of a Buy rating indicates that the overall positive sentiment towards Replimune Group remains unchanged. This mixed signal is likely to have a neutral short-term impact on the stock price as the market digests both the maintained confidence and the lowered expectations.